Trump Announces Sixth Vaccine Contract For 100 Million Doses


Covid-19- vaccine
In this file photo taken on July 10, 2020 A photo shows vaccines in prefilled, single-use syringes before the inspection and packaging phase at the French pharmaceutical company Sanofi’s world distribution centre in Val de Reuil, France.  JOEL SAGET / AFP


President Donald Trump on Tuesday announced a $1.5 billion contract with US biotech company Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May.
“I’m pleased to announce that we have reached an agreement with Moderna to manufacture and deliver 100 million doses of their coronavirus vaccine candidate,” Trump said at a White House news conference. “The federal government will own these vaccine doses, we’re buying them.”
“We’re on track to rapidly-produce 100 million doses as soon as the vaccine is approved, and up to 500 million shortly thereafter, so we’ll have 600 million doses,” he added.
Moderna, in partnership with the US National Institutes of Health (NIH), is conducting Phase 3 clinical trials of a vaccine candidate and manufacturing of vaccine doses will take place while the trials are underway.

Handout picture released by the Sao Paulo State Government press office showing a volunteer receiving the COVID-19 vaccine during the trial stage of the vaccine produced by the Chinese company Sinovac Biotech at the Hospital das Clinicas (HC) in Sao Paulo state, Brazil, on July 21, 2020.  Handout / Sao Paulo State Government / AFP

The vaccine, called mRNA-1273, is being co-developed by Moderna and the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), which is led by Dr Anthony Fauci.
Fauci has said researchers are unlikely to know the efficacy of the vaccine before the end of the year at the earliest. But Trump has said he hopes to have a vaccine before the November 3 presidential election.
The latest contract brings the US government’s total commitments to Moderna to $2.48 billion.
The company, founded less than 10 years ago, has not previously developed a vaccine of any kind but preliminary results of the company’s experimental COVID-19 vaccine have reportedly produced promising results.

U.S. President Donald Trump speaks to the media as he departs for Walter Reed National Military Medical Center from the White House on July 11, 2020 in Washington, DC. Joshua Roberts/Getty Images/AFP
File photo: U.S. President Donald Trump speaks to the media as he departs for Walter Reed National Military Medical Center from the White House on July 11, 2020 in Washington, DC. Joshua Roberts/Getty Images/AFP

The Trump administration has allocated a total of at least $10.9 billion for the development and manufacturing of a coronavirus vaccine.
It has already ordered 100 million vaccine doses from Johnson & Johnson, Novavax, Pfizer and Sanofi and 300 million from AstraZeneca.
AFP
Emmanuel Egobiambu

Follow us on twitter (ajuede.com) or on Instagram (ajuedeman) for details of the global situation presently.

Comments

Popular posts from this blog

Taylor Swift: 'White supremacy is repulsive. There is nothing worse'

Dr. Vladimir Zelenko has now treated 699 coronavirus patients with 100% success

ORIGIN OF THE AKAN - Onyeji Nnaji

GARDEN OF EDEN FOUND IN WEST AFRICA - Onyeji Nnaji

Tulsi Gabbard says impeachment of Trump would be 'terribly divisive' for country

TYPES OF PREPOSITION - Onyeji Nnaji

Marine Charged for Facebook Comments Gets Hearing Date

EGYPTIANS LAMBAST NIGERIAN FOOTBALLERS OVER ‘FREQUENT’ PROTESTS

THE ORIGIN AND HISTORY OF NSUKKA by Onyeji Nnaji